Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study tries to improve our treatments for people who have obsessive-compulsive disorder (OCD) by testing psilocybin, a mind altering drug that changes activity in brain areas involved in OCD. 30 patients with moderate or more severe OCD who are not taking mind altering medications or street drugs will participate in a 12 week study. Participants will be assigned (by luck of the draw) to take a low, medium, or high dose whole psilocybin mushroom contained in three chocolate pieces, prepared for this study by the Scottsdale Research Institute.
Epistemonikos ID: 1cbcb35edb65567336299be392257f3d833f9270
First added on: Jan 17, 2026